Mizuho analyst Ann Hynes raised the firm’s price target on BrightSpring Health (BTSG) to $38 from $32 and keeps an Outperform rating on the shares.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BTSG:
- BrightSpring Health price target raised to $41 from $30 at BTIG
- BrightSpring Health price target raised to $42 from $35 at UBS
- BrightSpring Health Services, Inc.: Strong Financial Performance and Growth Prospects Justify Buy Rating
- BrightSpring Health Services, Inc.: Strong Growth Prospects and Strategic Leverage Improvement Reinforce Buy Rating
- BrightSpring Health Services Reports Strong Q3 2025 Results